Our data with respect to AML-ETO driven AML suggests that the aged niche does not directly accelerate the disease-transition to a chronic phase – it rather accelerates the expansion of the aberrant dominant LIC clone (Figure 4B). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.